StonvexLoading…
StonvexStonvexStonvexCore line items from DWSN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $75.63M | $74.15M | $96.85M | $51.63M |
Operating Income | $-1.66M | $-4.55M | $-13.07M | $-22.20M |
Net Income | $-1.94M | $-4.12M | $-12.15M | $-18.64M |
EPS (Diluted) | $-0.06 | $-0.13 | $-0.45 | $-0.75 |
Total Assets | $56.01M | $30.87M | $57.52M | $68.67M |
Total Liabilities | $40.20M | $13.59M | Not available | Not available |
Cash & Equivalents | $4.91M | $1.39M | $10.77M | $18.60M |
Free Cash Flow OCF − CapEx | $7.15M | $-3.73M | $-2.91M | $-4.70M |
Shares Outstanding | 31.05M | 30.98M | 30.81M | 23.81M |